1,411
Views
0
CrossRef citations to date
0
Altmetric
ARTICLE

Economic Impact of Preoperative Meloxicam IV Administration in Total Knee Arthroplasty: A Randomized Trial Sub-Study

, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 150-162 | Received 07 Jul 2020, Accepted 22 Jan 2021, Published online: 19 Jul 2021

References

  • Barash P, Bieterman K, Hersey D. Game changers: the 20 most important anesthesia articles ever published. Anesth Analg. 2015;120(3):663–70. doi:10.1213/ane.0000000000000513.
  • Gerbershagen HJ, Aduckathil S, van Wijck AJ, Peelen LM, Kalkman CJ, Meissner W . Pain Intensity on the first day after surgery: a prospective cohort study comparing 179 surgical procedures. Anesthesiology. 2013;118(4):934–44. doi:10.1097/ALN.0b013e31828866b3.
  • Chan E, Blyth F, Nairn L, Fransen M. Acute postoperative pain following hospital discharge after total knee arthroplasty. Osteoarthritis Cartilage. 2013;21(9):1257–63. doi:10.1016/j.joca.2013.06.011.
  • Mangano DT, Hollenberg M, Fegert G, Meyer ML, London MJ, Tubau JF, Krupski WC . Perioperative myocardial ischemia in patients undergoing noncardiac surgery-I: Incidence and severity during the 4 day perioperative period. The study of perioperative ischemia (SPI) research group. J Am Coll Cardiol. 1991;17(4):843–50. doi:10.1016/0735-1097(91)90863-5.
  • Carr DB, Goudas LC. Acute pain. The Lancet. 1999;353(9169):2051–8. doi:10.1016/S0140-6736(99)03313-9.
  • Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, Poole S, Bonventre JV, Woolf CJ . Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature. 2001;410(6827):471–5. doi:10.1038/35068566.
  • Gan TJ. Poorly controlled postoperative pain: prevalence, consequences, and prevention. J Pain Res. 2017;10:2287–98. doi:10.2147/JPR.S144066.
  • Garimella V, Cellini C. Postoperative pain control. Clin Colon Rectal Surg. 2013;26(3):191–6. doi:10.1055/s-0033-1351138.
  • Chou R, Gordon DB, de Leon-Casasola OA, Rosenberg JM, Bickler S, Brennan T, Carter T, Cassidy CL, Chittenden EH, Degenhardt E, et al. Management of Postoperative Pain: a clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists’ committee on regional anesthesia, executive committee, and administrative council. J Pain. 2016;17(2):131–57. doi:10.1016/j.jpain.2015.12.008.
  • Lespasio MJ, Guarino A, Sodhi N, Mont MA. Pain management associated with total joint arthroplasty: A primer. Perm J. 2019;23:18–169. doi:10.7812/TPP/18-169.
  • Ricardo BM, Rajive AM, Nalini SM. Opioid complications and side effects. Pain Physician. 2008;11:S105–S20.
  • Ladha KS, Patorno E, Huybrechts KF, Liu J, Rathmell JP, Bateman BT. Variations in the use of perioperative multimodal analgesic therapy. Anesthesiology. 2016;124(4):837–45. doi:10.1097/aln.0000000000001034.
  • Gupta A, Bah M. NSAIDs in the treatment of postoperative pain. Curr Pain Headache Rep. 2016;20(11):62. doi:10.1007/s11916-016-0591-7.
  • Beck DE, Margolin DA, Babin SF, Russo CT. Benefits of a multimodal regimen for postsurgical pain management in colorectal surgery. Ochsner J. 2015;15(4):408–12.
  • Duellman TJ, Gaffigan C, Milbrandt JC, Allan DG. Multi-modal, pre-emptive analgesia decreases the length of hospital stay following total joint arthroplasty. Orthopedics. 2009;32(3):167.
  • Jin F, Chung F. Multimodal analgesia for postoperative pain control. J Clin Anesth. 2001;13(7):524–39. Epub 2001/11/13. doi:10.1016/s0952-8180(01)00320-8.
  • Halawi MJ, Grant SA, Bolognesi MP. Multimodal analgesia for total joint arthroplasty. Orthopedics. 2015;38(7):e616–e625. doi:10.3928/01477447-20150701-61.
  • McDonald LT, Corbiere NC, DeLisle JA, Clark AM, Kuxhaus L. Pain management after total joint arthroplasty. AORN Journal. 2016;103(6):605–16. doi:10.1016/j.aorn.2016.04.003.
  • Hou J, Li W, Chen Y, Yang L, Li L, Zhao L. Early preoperative versus postoperative administration of meloxicam in pain control, patient global status improvement, knee function recovery of arthroscopic knee surgery. Medicine (Baltimore). 2019;98(40):e17133. doi:10.1097/MD.0000000000017133.
  • Berry P. National Pharmaceutical Council. Pain: Current Understanding of Assessment, Management, and Treatments 2001. https://www.npcnow.org/publication/pain-currentunderstanding-assessment-management-and-treatments.
  • Davies NM, Skjodt NM. Clinical pharmacokinetics of meloxicam. A cyclo-oxygenase-2 preferential nonsteroidal anti-inflammatory drug. Clin Pharmacokinet. 1999;36(2):115–26. doi:10.2165/00003088-199936020-00003.
  • Del Tacca M, Colucci R, Fornai M, Blandizzi C. Efficacy and tolerability of meloxicam, a COX-2 preferential nonsteroidal anti-inflammatory drug: A review. Clin Drug Invest. 2002;22(12):799–818. doi:10.2165/00044011-200222120-00001.
  • Christensen SE, Cooper SA, Mack RJ, McCallum SW, Du W, Freyer A . A randomized double-blind controlled trial of intravenous meloxicam in the treatment of pain following dental impaction surgery. J Clin Pharmacol. 2018;58(5):593–605. doi:10.1002/jcph.1058.
  • Pollak RA, Gottlieb IJ, Hakakian F, Zimmerman JC, McCallum SW, Mack RJ, Keller R, Freyer A, Du W . Efficacy and safety of intravenous meloxicam in patients with moderate-to-severe pain following bunionectomy: a randomized, double-blind, placebo-controlled trial. Clin J Pain. 2018;34(10):918–26. doi:10.1097/AJP.0000000000000609.
  • Bergese SD, Melson TI, Candiotti KA, Ayad SS, Mack RJ, McCallum SW, Du W, Gomez A, Marcet JE. A phase 3, randomized, placebo‐controlled evaluation of the safety of intravenous meloxicam following major surgery. Clin Pharmacol Drug Dev. 2019;8(8):1062–72. doi:10.1002/cpdd.666.
  • Memtsoudis SG, Poeran J, Zubizarreta N, Cozowicz C, Mörwald EE, Mariano ER, Mazumdar M. Association of multimodal pain management strategies with perioperative outcomes and resource utilization: a population-based study. Anesthesiology. 2018;128(5):891–902. doi:10.1097/aln.0000000000002132.
  • Berkowitz RSR, Sah AP, Mack RJ, McCallum SW, Du W, Black LK, Freyer A, Coyle E. Safety and efficacy of perioperative intravenous meloxicam for moderate-to-severe pain management in total knee arthroplasty: a randomized clinical trial. Unpublished manuscript. 2020.
  • Lehmann N, Joshi GP, Dirkmann D, Weiss M, Gulur P, Peters J, Eikermann M. Development and longitudinal validation of the overall benefit of analgesia score: a simple multi-dimensional quality assessment instrument. Br J Anaesth. 2010;105(4):511–8. doi:10.1093/bja/aeq186.
  • YaDeau JT, Liu SS, Rade MC, Marcello D, Liguori GA. Performance characteristics and validation of the Opioid-Related Symptom Distress Scale for evaluation of analgesic side effects after orthopedic surgery. Anesth Analg. 2011;113(2):369–77. doi:10.1213/ANE.0b013e31821ae3f7.
  • Cammu G, De WJ, De VJ, Byttebier G, Vandeput D, Foubert L. Postoperative residual paralysis in outpatients versus inpatients. Anesth Analg. 2006;102(2):426–9. doi:10.1213/01.ane.0000195543.61123.1f.
  • Suresh K, Chandrashekara S. Sample size estimation and power analysis for clinical research studies. J Hum Reprod Sci. 2012;5(1):7–13. doi:10.4103/0974-1208.97779.
  • National Organization for Rare Diseases. Arginase-1 Deficiency. https://rarediseases.org/rare-diseases/arginase-deficiency/.
  • Maiese BA, Pham AT, Shah MV, Eaddy MT, Lunacsek OE, Wan GJ. Hospitalization costs for patients undergoing orthopedic surgery treated with intravenous acetaminophen (IV-APAP) plus other IV analgesics or IV opioid monotherapy for postoperative pain. Adv Ther. 2017;34(2):421–35. doi:10.1007/s12325-016-0449-8.
  • Lovald ST, Ong KL, Malkani AL, Lau EC, Schmier JK, Kurtz SM, Manley MT. Complications, mortality, and costs for outpatient and short-stay total knee arthroplasty patients in comparison to standard-stay patients. J Arthroplasty. 2014;29(3):510–5. doi:10.1016/j.arth.2013.07.020.
  • Smith SR, Bido J, Collins JE, Yang H, Katz JN, Losina E. Impact of preoperative opioid use on total knee arthroplasty outcomes. J Bone Joint Surg Am. 2017;99(10):803–8. doi:10.2106/JBJS.16.01200.
  • Sing DC, Barry JJ, Cheah JW, Vail TP, Hansen EN. Long-acting opioid use independently predicts perioperative complication in total joint arthroplasty. J Arthroplasty. 2016;31(9):170–4.e1. doi:10.1016/j.arth.2016.02.068.
  • Kessler ER, Shah M, K, Gruschkus S, Raju A . Cost and quality implications of opioid-based postsurgical pain control using administrative claims data from a large health system: opioid-related adverse events and their impact on clinical and economic outcomes. Pharmacotherapy: J Human Pharmacol Drug Ther. 2013;33(4):383–91. doi:10.1002/phar.1223.
  • Halawi MJ, Vovos TJ, Green CL, Wellman SS, Attarian DE, Bolognesi MP. Opioid-based analgesia: impact on total joint arthroplasty. J Arthroplasty. 2015;30(12):2360–3. doi:10.1016/j.arth.2015.06.046.
  • Minkowitz HS, Gruschkus SK, Shah M, Raju A. Adverse drug events among patients receiving postsurgical opioids in a large health system: risk factors and outcomes. Am J Health Syst Pharm. 2014;71(18):1556–65. doi:10.2146/ajhp130031.
  • Crawford DA, Scully W, McFadden L, Manoso M. Preoperative predictors of length of hospital stay and discharge disposition following primary total knee arthroplasty at a military medical center. Mil Med. 2011;176(3):304–7. doi:10.7205/milmed-d-10-00042.
  • Smith I, Elton R, Ballantyne J, Brenkel I. Pre-operative predictors of the length of hospital stay in total knee replacement. J Bone Joint Surg Br. 2008;90(11):1435–40. doi:10.1302/0301-620X.90B11.20687.
  • Kreder HJ, Grosso P, Williams JI, Jaglal S, Axcell T, Wai EK, et al. Provider volume and other predictors of outcome after total knee arthroplasty: a population study in Ontario. Can J Surg. 2003;46(1):15.
  • Schwarzkopf R, Brodsky M, Garcia GA, Gomoll AH. Surgical and functional outcomes in patients undergoing total knee replacement with patient-specific implants compared with “off-the-shelf” implants. Orthopaed J Sports Med. 2015;3(7):2325967115590379. doi:10.1177/2325967115590379.
  • Robinson K, Wagstaff K, Sanghera S, Kerry R. Postoperative pain following primary lower limb arthroplasty and enhanced recovery pathway. Annals 2014;96(4):302–6. doi:10.1308/003588414X13946184900525.
  • Coley KC, Williams BA, DaPos SV, Chen C, Smith RB. Retrospective evaluation of unanticipated admissions and readmissions after same day surgery and associated costs. J Clin Anesth. 2002;14(5):349–53. doi:10.1016/S0952-8180(02)00371-9.
  • Morrison SR, Magaziner J, McLaughlin MA, Orosz G, Silberzweig SB, Koval KJ, Siu AL. The impact of post-operative pain on outcomes following hip fracture. Pain. 2003;103(3):303–11. doi:10.1016/S0304-3959(02)00458-X.
  • Goesling J, Moser SE, Zaidi B, Hassett AL, Hilliard P, Hallstrom B, Clauw DJ, Brummett CM . Trends and predictors of opioid use after total knee and total hip arthroplasty. Pain. 2016;157(6):1259–65. doi:10.1097/j.pain.0000000000000516.